Contraceptive use in HIV-positive women

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 2, 2004, Pages 714-720

  Heard, Isabelle ^a   Potard, Valérie ^b   Costagliola, Dominique ^b   Kazatchkine, Michel D ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

Author keywords

Condom; Contraception; HIV infection; Serodiscordant couples

Indexed keywords

ANTIRETROVIRUS AGENT; CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONDOM; CONTRACEPTION; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PATIENT COUNSELING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ADULT; COHORT STUDIES; CONTRACEPTION; CONTRACEPTION BEHAVIOR; FEMALE; FRANCE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEXUAL PARTNERS;

EID: 2542455816     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200406010-00008     Document Type: Article

References (30)

1. Olaitan A, Madge S, Johnson M. Contraceptive use, and knowledge of postcoital contraception amongst HIV-infected women: a comparison with an HIV negative population. Br J Fam Plann. 1996;22:127-128.
2. Chen J, Phillips K, Kanouse D, et al. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect. 2001;33:144-152.
3. Lindsay M, Grant J, Peterson H, et al. The impact of knowledge of human immunodeficiency virus serostatus on contraceptive choice and repeat pregnancy. Obstet Gynecol. 1995;85:675-679.
4. Davis K, Welker S. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect. 1999;31:272-279.
5. De Vincenzi I. Longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med. 1994;331:341-346.
6. Allen S, Meinzen-Derr J, Kautzman M, et al. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS. 2003;17:733-740.
7. Nicolosi A, Musicco M, Saracco A, et al. Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus. Italian Study Group on HIV Heterosexual Transmission. J Acquir Immune Defic Syndr. 1994;7:296-300.
8. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F, et al., eds. Contraceptive Technology. New York: Ardent Media; 1998: 779-844.
9. IPPF International Medical Advisory Panel. IMAP Statement on dual protection against unwanted pregnancy and sexually transmitted infections including HIV. IPPF Med Bull. 2000:34.
10. Critelli J, Suire D. Obstacles to condom use: the combination of other forms of birth control and short-term monogamy. J Am Coll Health. 1998; 46:215-219.
11. Magalhaes J, Amaral E, Giraldo PC, et al. HIV infection in women: impact on contraception. Contraception. 2002;66:87-91.
12. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
13. Toulemon L, Leridon H. Contraceptive practices and trends in France. Fam Plann Perspect. 1998;30:114-120.
14. Buchacz K, van der Straten A, Saul J, et al. Sociodemographic, behavioral, and clinical correlates of inconsistent condom use in HIV-serodiscordant heterosexual couples. J Acquir Immune Defic Syndr. 2001; 28:289-297.
15. Wilson TE, Massad LS, Riester KA, et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results from the Women's Interagency HIV Study. AIDS. 1999;13:591-598.
16. Centers for Disease Control and Prevention. Surgical sterilization among women and use of condoms: Baltimore, 1989-1990. MMWR Morb Mortal Wkly Rep. 1992;41:568-569, 575.
17. Diaz T, Schable B, Chu SY. Relationship between use of condoms and other forms of contraception among human immunodeficiency virus-infected women. Supplement to HIV and AIDS Surveillance Project Group. Obstet Gynecol. 1995;86:277-282.
18. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663-1671.
19. Mayaux M, Téglas J, Blanche S. Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French national cohort. J Acquir Immune Defic Syndr. 2003;34:338-343.
20. Sellmeyer DE, Grunfeld C. Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome. Endocr Rev. 1996;17:518-532.
21. Collazos J, Martinez E, Mayo J, et al. Sexual dysfunction in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:322-326.
22. Hecht FM, Grant RM, Petropoulos CJ, et al. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors. N Engl J Med. 1998;339:307-311.
23. Goulder P, Walker B. HIV-1 superinfection, a word of caution. N Engl J Med. 2002;347:756-758.
24. Anzala OA, Nagelkerke NJ, Bwayo JJ, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis. 1995;171:686-689.
25. Goedert JJ, Eyster ME, Biggar RJ, et al. Heterosexual transmission of human immunodeficiency virus: association with severe depletion of T-helper lymphocytes in men with hemophilia. AIDS Res Hum Retroviruses. 1987;3:355-361.
26. Lavoie R, Otis J, Leclerc R. Attitudes towards the triple-therapies and safer sex: what a mix. Paper presented at: XII International AIDS Conference; June 28-July 3, 1998; Geneva. Abstract 3427.
27. Desquilbet L, Deveau C, Goujard C, et al. PRIMO Cohort Study Group. Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort. AIDS. 2002;16:2329-2333.
28. van der Straten A, Gomez CA, Saul J, et al. Sexual risk behaviors among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS. 2000;14:F47-F54.
29. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Report of the NIH Panel to Define Principles of Therapy of HIV Infection. MMWR Morb Mortal Wkly Rep. 1998;47/No. RR-05): 1-47.
30. Delfraissy JF. Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group. Medecine-Sciences, Flammarion; 2002.